Literature DB >> 23983905

Small bowel carcinoid: Location isn't everything!

Danielle M Hari1, Stephanie L Goff, Heidi J Reich, Anna M Leung, Myung-Shin Sim, Ji Hey Lee, Edward Wolin, Farin Amersi.   

Abstract

AIM: To investigate the prognostic significance of the primary site of disease for small bowel carcinoid (SBC) using a population-based analysis.
METHODS: The Surveillance, Epidemiology and End Results (SEER) database was queried for histologically confirmed SBC between the years 1988 and 2009. Overall survival (OS) and disease-specific survival (DSS) were analyzed using the Kaplan-Meier method and compared using Log rank testing. Log rank and multivariate Cox regression analyses were used to identify predictors of survival using age, year of diagnosis, race, gender, tumor histology/size/location, tumor-node-metastasis stage, number of lymph nodes (LNs) examined and percent of LNs with metastases.
RESULTS: Of the 3763 patients, 51.2% were male with a mean age of 62.13 years. Median follow-up was 50 mo. The 10-year OS and DSS for duodenal primaries were significantly better when compared to jejunal and ileal primaries (P = 0.02 and < 0.0001, respectively). On multivariate Cox regression analysis, after adjusting for multiple factors, primary site location was not a significant predictor of survival (P = 0.752 for OS and P = 0.966 DSS) while age, number of primaries, number of LNs examined, T-stage and M-stage were independent predictors of survival.
CONCLUSION: This 21-year, population-based study of SBC challenges the concept that location of the primary lesion alone is a significant predictor of survival.

Entities:  

Keywords:  National Comprehensive Cancer network guidelines; Primary tumor location; Prognosis; Small bowel carcinoid; Survival

Year:  2013        PMID: 23983905      PMCID: PMC3753437          DOI: 10.4240/wjgs.v5.i8.239

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  31 in total

1.  Lymph node harvest in colon cancer specimens depends on tumour factors, patients and doctors, but foremost on specimen handling.

Authors:  Kristian Storli; Christian Fredrik Lindboe; Camilla Kristoffersen; Karina Kleiven; Karl Søndenaa
Journal:  APMIS       Date:  2010-12-01       Impact factor: 3.205

2.  Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

3.  Survival and prognostic factors in patients with small bowel carcinoid tumour.

Authors:  K Landerholm; N Zar; R E Andersson; S E Falkmer; J Järhult
Journal:  Br J Surg       Date:  2011-08-19       Impact factor: 6.939

Review 4.  Malignant tumours of the small intestine: a review of histopathology, multidetector CT and MRI aspects.

Authors:  M Anzidei; A Napoli; C Zini; M A Kirchin; C Catalano; R Passariello
Journal:  Br J Radiol       Date:  2011-05-17       Impact factor: 3.039

5.  Follow-up of known carcinoid liver metastases: is respiratory-gated t(2) fast spin-echo enough?

Authors:  Priya Bhosale; Jin Wei Kwek; Revathy Iyer; Wei Wei; Roland Bassett; Vikas Kundra
Journal:  Neuroendocrinology       Date:  2011-04-07       Impact factor: 4.914

Review 6.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

7.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Authors:  Anja Rinke; Hans-Helge Müller; Carmen Schade-Brittinger; Klaus-Jochen Klose; Peter Barth; Matthias Wied; Christina Mayer; Behnaz Aminossadati; Ulrich-Frank Pape; Michael Bläker; Jan Harder; Christian Arnold; Thomas Gress; Rudolf Arnold
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

8.  Proposed staging system for gastrointestinal carcinoid tumors.

Authors:  Christine S Landry; Kelly M McMasters; Charles R Scoggins; Robert C G Martin
Journal:  Am Surg       Date:  2008-05       Impact factor: 0.688

9.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

10.  Small-bowel neoplasms: prospective evaluation of MR enteroclysis.

Authors:  Gabriele Masselli; Elisabetta Polettini; Emanuele Casciani; Luca Bertini; Amorino Vecchioli; Gianfranco Gualdi
Journal:  Radiology       Date:  2009-03-20       Impact factor: 11.105

View more
  4 in total

1.  Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.

Authors:  Timothy Weatherall; Jason Denbo; John Sharpe; Michael Martin; Thomas O'Brien; Rajib Gupta; Kenneth Groshart; Stephen Behrman; Paxton Dickson
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

Review 2.  Management of gastric and duodenal neuroendocrine tumors.

Authors:  Yuichi Sato; Satoru Hashimoto; Ken-Ichi Mizuno; Manabu Takeuchi; Shuji Terai
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

3.  Multifocality in Small Bowel Neuroendocrine Tumors.

Authors:  Alexandra Gangi; Emily Siegel; Galinos Barmparas; Simon Lo; Laith H Jamil; Andrew Hendifar; Nicholas N Nissen; Edward M Wolin; Farin Amersi
Journal:  J Gastrointest Surg       Date:  2017-11-08       Impact factor: 3.452

4.  Mesenteric changes in an ultrasound examination can facilitate the diagnosis of neuroendocrine tumors of the small intestine.

Authors:  Andrzej Smereczyński; Teresa Starzyńska; Katarzyna Kołaczyk
Journal:  J Ultrason       Date:  2015-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.